Ra Capital Nexus Fund Iii, L.P.
Director at Artiva Biotherapeutics, Inc. (ARTV); Director at Parabilis Medicines, Inc. (PBLS); Director at Sionna Therapeutics, Inc. (SION)
Purchase track record
Strong record. Based on 2 purchases with a full 90 days of price history.
85
Avg. 90-day return+28.4%
vs. S&P 500+25.8%
Beat the market100%
Paper profit on buys+$129M
Total bought / sold$499M / $14.8M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 28SEC | ARTVArtiva Biotherapeutics, Inc. | Buy | 41,31917,283,802 held (+0%) | $9.99 | $413K | -30.5% |
| Jun 15SEC | PBLSParabilis Medicines, Inc. | Buy | 19,728,35326,285,093 held (+301%) | $20.00 | $395M | +37.4% |
| Jun 15SEC | PBLSParabilis Medicines, Inc. | Buy | 1,460,3972,648,278 held (+123%) | $20.00 | $29.2M | +37.4% |
| May 13SEC | ARTVArtiva Biotherapeutics, Inc. | Buy | 6,510,41615,203,995 held (+75%) | $11.52 | $75.0M | -39.8% |
| Oct 28SEC | SIONSionna Therapeutics, Inc. | Sell | 14,1166,909,249 held (−0%) | $39.50 | $558K | -87.6% |
| Oct 28SEC | SIONSionna Therapeutics, Inc. | Sell | 122,271747,380 held (−14%) | $39.50 | $4.8M | -87.6% |
| Oct 28SEC | SIONSionna Therapeutics, Inc. | Sell | 66,6722,257,826 held (−3%) | $39.50 | $2.6M | -87.6% |
| Oct 28SEC | SIONSionna Therapeutics, Inc. | Sell | 107,941219,867 held (−33%) | $39.50 | $4.3M | -87.6% |
| Oct 28SEC | SIONSionna Therapeutics, Inc. | Sell | 3,6246,905,625 held (−0%) | $39.58 | $143K | -87.6% |
| Oct 28SEC | SIONSionna Therapeutics, Inc. | Sell | 31,392715,988 held (−4%) | $39.58 | $1.2M | -87.6% |
| Oct 28SEC | SIONSionna Therapeutics, Inc. | Sell | 17,1182,240,708 held (−1%) | $39.58 | $678K | -87.6% |
| Oct 28SEC | SIONSionna Therapeutics, Inc. | Sell | 10,476209,391 held (−5%) | $39.58 | $415K | -87.6% |
- Buy
Director Ra Capital Nexus Fund Iii, L.P. bought $395M of PBLS at $20.00 — first open-market purchase in our records; raises the stake by 301%.
- Buy
Director Ra Capital Nexus Fund Iii, L.P. bought $29.2M of PBLS at $20.00 — raises the stake by 123%.
- Buy
Director Ra Capital Nexus Fund Iii, L.P. bought $75.0M of ARTV at $11.52 — first open-market purchase in our records; raises the stake by 75%.
- Sell
Director Ra Capital Nexus Fund Iii, L.P. sold $4.3M of SION at $39.50 — cuts the stake by 33%.